| Bioactivity | 5-Methoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | ||||||||||||
| Name | 5-Methoxyuridine | ||||||||||||
| CAS | 35542-01-9 | ||||||||||||
| Formula | C10H14N2O7 | ||||||||||||
| Molar Mass | 274.23 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
5-Methoxyuridine
CAS: 35542-01-9 F: C10H14N2O7 W: 274.23
5-Methoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indole
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.